思密达治疗老年慢性结肠炎疗效观察

Treatment of chronic colitis in senile patients with smecta.

为探讨思密达对老年慢性结肠炎的治疗作用,从1994年7月～1996年6月对我院收治的55例慢性结肠炎病人分别使用中药和思密达灌肠治疗。55例病人根据症状、化验和内镜检查确诊。诊断标准符合太原会议诊断标准。思密达组30例,将思密达每次6g溶于100mL温盐水中保留灌肠,每晚1次,2周为1疗程。中药采用石榴皮、白头翁、蒲公英等水煎至100mL保留灌肠,每晚1次,2周为1疗程。结果显示显效率思密达组为86.7％,中药组为52.0％,总有效率思密达组为96.7％,中药组为88.0％。思密达组明显优于中药组(P<0.05)。

In order to probe into the effect of smecta in the treatment of chronic colitis in senile patients, since July 1994 to June 1996, 55 cases of this disease were treated by enema with smecta or traditional Chinese medicine respectively. This 55 cases were difinitely diagnosed through their symptoms, laboratory tests and endoscopic observations. Their diagnostic criterion accorded with that formulated in the Tanyuan conference. The smecta group consisted of 30 cases. They were treated by retention enema with 6 grams smecta dissolved in 100 mL warm saline, once for each night, two weeks as a treatment course. The traditional Chinese medicine group consisted of 25 cases, their retention enema solution was pericarp of common pomegranate, radix pulsatillae and herba teraxaci etc decocted to 100 mL. also once for each night, two weeks as a course. Results showed the valid rate of smecta group was 86. 7%, and that of traditional Chinese medicine group was 52% (P<0. 05), while the total effective rate of the former was 96. 75% and that of the latter was 88% (P<0. 05). Results demonstrated that smecta is an ideal drug for treatment of chronic colitis in senile patients.